These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Clinical efficacy of a herpes simplex subunit vaccine. Cappel R, Sprecher S, De Cuyper F, De Braekeleer J. J Med Virol; 1985 Jun 11; 16(2):137-45. PubMed ID: 2989419 [Abstract] [Full Text] [Related]
35. Experimental immunosuppression induced by herpes simplex virus. Cappel R, Henry C, Thiry L. Arch Virol; 1975 Sep 11; 49(1):67-72. PubMed ID: 172950 [Abstract] [Full Text] [Related]
36. High frequency of detection of herpes simplex virus DNA in the oral cavity of patients with eczema herpeticum. Yoshida M, Amatsu A. Dermatology; 2004 Sep 11; 209(2):101-3. PubMed ID: 15316162 [Abstract] [Full Text] [Related]
37. Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs. Donnenberg AD, Chaikof E, Aurelian L. Infect Immun; 1980 Oct 11; 30(1):99-109. PubMed ID: 6254886 [Abstract] [Full Text] [Related]
38. In vitro induction of human cell-mediated cytotoxicity directed against herpes simplex virus-infected cells. Kinetics in normal donors and patients with recurrent herpes labialis. Rola-Pleszczynski M. J Clin Lab Immunol; 1981 Jul 11; 6(1):39-43. PubMed ID: 7265173 [Abstract] [Full Text] [Related]
39. A comparative study between viral isolation and indirect immunofluorescence in the diagnosis of herpes simplex virus. Galadari I, Fowzan AW. Eur Ann Allergy Clin Immunol; 2006 Feb 11; 38(2):62-4. PubMed ID: 16711539 [Abstract] [Full Text] [Related]